4.5 Article

Combined metabolomics and gut microbiome to investigate the effects and mechanisms of Yuquan Pill on type 2 diabetes in rats

出版社

ELSEVIER
DOI: 10.1016/j.jchromb.2023.123713

关键词

Metabolomics; Diabetes; Gut microbiota; Yuquan Pill

向作者/读者索取更多资源

Yuquan Pill (YQP), a traditional Chinese medicine, has been used for many years in treating type 2 diabetes (T2DM) in China and has shown beneficial clinical effects. In this study, the antidiabetic mechanism of YQP was investigated for the first time using metabolomics and intestinal microbiota. The results demonstrated that YQP effectively improved insulin resistance, relieved hyperglycemia, and reduced hyperlipidemia associated with T2DM. It was also found that YQP regulated metabolism and gut microbiota in T2DM rats through identified metabolic pathways and abundance modulation of specific bacteria.
Yuquan Pill (YQP) is a traditional Chinese medicine (TCM) for the treatment of type 2 diabetes (T2DM) in China for many years, and has a beneficial clinical effect. In this study, the antidiabetic mechanism of YQP was investigated for the first time from the perspective of metabolomics and intestinal microbiota. After 28 days of high-fat feeding, rats were injected intraperitoneally with streptozotocin (STZ, 35 mg/kg) followed by a single oral administration of YQP 2.16 g/kg and metformin 200 mg/kg for 5 weeks. The results showed that YQP was effectively improved insulin resistance and alleviated hyperglycemia and hyperlipidemia associated with T2DM. YQP was found to regulate metabolism and gut microbiota in T2DM rats using untargeted metabolomics and gut microbiota integration. Forty-one metabolites and five metabolic pathways were identified, including Ascorbate and aldarate metabolism, Nicotinate and nicotinamide metabolism, Galactose metabolism, Pentose phosphate pathway and Tyrosine metabolism. YQP can regulate T2DM-induced dysbacteriosis by modulating the abun-dance of Firmicutes, Bacteroidetes, Ruminococcus, Lactobacillus. The restorative effects of YQP in rats with T2DM have been confirmed and provide a scientific basis for the clinical treatment of diabetic patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据